Doximity Inc’s stock has reached a 52-week low, touching a price of $43.17. The stock closed at $42.75 in recent trading, down significantly from its 52-week high of $85.21. This milestone marks a ...
Doximity Inc. (NYSE:DOCS) is one of the oversold stocks to buy now. On December 15, Morgan Stanley upgraded Doximity to Overweight from Equal Weight with a price target of $65, which was increased ...
Investing.com - Raymond James has reiterated its Strong Buy rating and $65.00 price target on Doximity Inc (NYSE:DOCS) as the healthcare technology company faces growing competition in AI-assisted ...
Will Doximity’s (DOCS) AI Momentum and US$31 Million Settlement Shift Its Core Investment Narrative?
In December 2025, Doximity, Inc. reached a US$31,000,000 insurance-funded settlement agreement to resolve a federal securities lawsuit, pending court approval and without any admission of liability or ...
Ladies and gentlemen, thank you for standing by. My name is Christa, and I will be your conference operator today. At this time, I would like to welcome you to the Doximity Second Quarter 2026 ...
Good day, everyone, and welcome to Doximity's First Quarter 2026 Conference Call. At this time, I would like to hand the call over to Mr. Perry Gold. Please go ahead, sir. Perry Scott Gold Thank you, ...
Doximity has acquired the AI startup Pathway Medical for $63 million. Pathway has one of the largest structured datasets in medicine, Doximity said. The integration is underway, and the companies are ...
These top telehealth stocks look like smart growth plays right now. It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal ...
It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal process. You need to consider the type of stocks you want to buy, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results